Precisely Tuned Inhibition of HIF Prolyl Hydroxylases Is Key for Cardioprotection After Ischemia. (2021)
Attributed to:
Defining a protein hydroxylase tumour suppressor pathway
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1161/circresaha.120.318216
PubMed Identifier: 33626887
Publication URI: http://europepmc.org/abstract/MED/33626887
Type: Journal Article/Review
Volume: 128
Parent Publication: Circulation research
Issue: 8
ISSN: 0009-7330